Abstract: Pyrimidine deriviatives are ubiquination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.
Type:
Grant
Filed:
November 7, 2007
Date of Patent:
October 9, 2012
Assignee:
Proteologics, Ltd.
Inventors:
Philippe Nakache, Itzchak Angel, Nurit Livnah, Maxim Borovitov
Abstract: Provided are quinazolin-4(3A)-one derivatives, which are inhibitors of the ubiquitin ligase activity of a human polypeptide, particularly to POSH inhibitors, and to compositions and methods for the treatment RING E3 ubiquitin ligase related diseases.
Abstract: Pyrimidine deriviatives are ubiquination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.
Type:
Application
Filed:
November 7, 2007
Publication date:
July 15, 2010
Applicant:
Proteologics Ltd
Inventors:
Philippe Nakache, Itzchak Angel, Nurit Livnah, Maxim Borovitov
Abstract: The application discloses compounds that inhibit ubiquitin ligase activity. The application further discloses antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders.
Abstract: The invention provides, inter alia, methods for identifying substrates for E3 proteins that mediate ligation of ubiquitin or ubiquitin-like proteins.
Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
Type:
Application
Filed:
January 6, 2005
Publication date:
February 16, 2006
Applicant:
Proteologics, Ltd.
Inventors:
Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
Abstract: The application discloses novel polypeptides and nucleic acids involved in a variety of biological processes, including viral reproduction. Related methods and compositions are also described.
Type:
Application
Filed:
January 7, 2005
Publication date:
January 26, 2006
Applicant:
Proteologics, Ltd.
Inventors:
Iris Alroy, Tsvika Greener, Shmuel Tuvia, Danny Ben-Avraham
Abstract: The application relates to methods of inhibiting a Nef-mediated process in a cell infected with HIV. The application also provides methods and compositions for treating POSH-associated and HERPUD1-associated diseases such as viral disorders.
Abstract: The invention provides, inter alia, methods for identifying substrates for E3 proteins that mediate ligation of ubiquitin or ubiquitin-like proteins.